Follow
Anagha J Deshpande
Anagha J Deshpande
Mayo Clinic Alix School of Medicine
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Brexucabtagene autoleucel: a breakthrough in the treatment of mantle cell lymphoma.
A Deshpande, Y Wang, J Munoz, P Jain
Drugs of Today (Barcelona, Spain: 1998) 58 (6), 283-298, 2022
62022
Radiation and chimeric antigen receptor T-cell therapy in B-cell non-Hodgkin lymphomas
A Deshpande, W Rule, A Rosenthal
Current Treatment Options in Oncology 23 (1), 89-98, 2022
62022
Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
A Deshpande, J Munoz
Therapeutics and Clinical Risk Management, 657-668, 2022
42022
PopInf: an approach for reproducibly visualizing and assigning population affiliation in genomic samples of uncertain origin
AM Taravella Oill, AJ Deshpande, HM Natri, MA Wilson
Journal of Computational Biology 28 (3), 296-303, 2021
42021
Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer
AJ Deshpande, A Bhandarkar, WV Bobo, M Bydon, S Niazi, S McLaughlin
The American Journal of Surgery 226 (1), 4-10, 2023
22023
Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver
A Deshpande, J Munoz, K Kelemen, V Dabak, A Hanbali, R Kurzrock
Journal of Immunotherapy and Precision Oncology 6 (1), 56-58, 2023
12023
Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies
A Deshpande, J Munoz
Frontiers in Oncology 12, 948513, 2022
12022
Analysis of gender-based authorship trends in leading pain-medicine journals over 10 years
N Strand, M Kraus, C Pougnier, A Keim, A Deshpande, J Maloney
Health Psychology Research 10 (4), 2022
12022
Isoform Variation across Triple Negative Breast Cancer and Prostate Cancer
AJ Deshpande
2019
The system can't perform the operation now. Try again later.
Articles 1–9